MSI-H TUMORS

Clinical trials for MSI-H TUMORS explained in plain language.

Never miss a new study

Get alerted when new MSI-H TUMORS trials appear

Sign up with your email to follow new studies for MSI-H TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hopeful new combo for tough cancers that outsmarted First-Line treatment

Disease control Recruiting now

This study is testing a new two-drug immunotherapy combination for people with advanced cancers that have a specific genetic feature (MSI-H) and have stopped responding to a prior type of immunotherapy. It aims to see if this new combination can shrink tumors and is safe for pati…

Matched conditions: MSI-H TUMORS

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

MSI-H TUMORS

Get alerted when new MSI-H TUMORS trials appear

Hopeful new combo for tough cancers that outsmarted First-Line treatment